Short stature is a common clinical presentation, thus it is widely accepted that it is a polygenic trait. However, genome wide association and next generation sequencing studies have recently challenged this view, suggesting that many of the children classified as idiopathic short stature could instead have monogenic defects. Linear growth is determined primarily by chondrogenesis at the growth plate. This process results from chondrocyte proliferation, hypertrophy, and extracellular matrix secretion, and it is perfectly coordinated by complex networks of local paracrine and endocrine factors. Alterations in genes which control growth plate development can explain a large number of cases of isolated short stature, allowing an etiological diagnosis.
We reviewed recent data on the genetic alterations in fundamental cellular processes, paracrine signaling, and cartilage matrix formation associated with impaired growth plate chondrogenesis. In particular we focused on growth plate gene involvement in nonsyndromic short stature.
The identification of genetic basis of growth failure will have a significant impact on the care of children affected with short stature.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
A.R. Wood, T. Esko, J. Yang, S. Vedantam, T.H. Pers, S. Gustafsson et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46, 1173–1186 (2014)
E. Marouli, M. Graff, C. Medina-Gomez, K.S. Lo, A.R. Wood, T.R. Kjaer et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186–190 (2017)
J. Baron, L. Sävendahl, F. De Luca, A. Dauber, M. Phillip, J.M. Wit et al. Short and tall stature: a new paradigm emerges. Nat. Rev. Endocrinol. 11, 735–746 (2015)
A. Dauber, M.T. Muñoz-Calvo, V. Barrios, H.M. Domené, S. Kloverpris, C. Serra-Juhé et al. Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability. EMBO Mol. Med. 8, 363–374 (2016)
M.R. Jepsen, S. Kløverpris, J.H. Mikkelsen, J.H. Pedersen, E.M. Füchtbauer, L.S. Laursen et al. Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. J. Biol. Chem. 290, 3430–3439 (2015)
P. Kruszka, A.R. Porras, Y.A. Addissie, A. Moresco, S. Medrano, G.T.K. Mok et al. Noonan syndrome in diverse populations. Am. J. Med. Genet. A 173, 2323–2334 (2017)
M.F. Faienza, L. Giordani, M. Ferraris, G. Bona, L. Cavallo, PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link? Pediatr. Cardiol. 30, 1012–1015 (2009)
G.A. Vasques, N.L.M. Andrade, A.A.L. Jorge, Genetic causes of isolated short stature. Arch. Endocrinol. Metab. 63, 70–78 (2019)
Y.H. Jee, J. Baron, O. Nilsson, New developments in the genetic diagnosis of short stature. Curr. Opin. Pediatr. 30, 541–547 (2018)
O. Nilsson, R. Marino, F. De Luca, M. Phillip, J. Baron, Endocrine regulation of the growth plate. Horm. Res. 64, 157–165 (2005)
H.M. Kronenberg, Developmental regulation of the growth plate. Nature 423, 332–336 (2003)
G. Brunetti, G. D’Amato, M. Chiarito, A. Tullo, G. Colaianni, S. Colucci et al. An update on the role of RANKL-RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases. World J. Pediatr. 15, 4–11 (2019)
M.F. Faienza, A. Ventura, M. Delvecchio, A. Fusillo, L. Piacente, G. Aceto et al. High sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 102, 1174–1181 (2017)
G. Brunetti, F. Papadia, A. Tummolo, R. Fischetto, F. Nicastro, L. Piacente et al. Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α. Osteoporos. Int. 27, 2355–2365 (2016)
Y. Rellmann, R. Dreier, Different forms of ER stress in chondrocytes result in short stature disorders and degenerative cartilage diseases: new insights by cartilage-specific ERp57 knockout mice. Oxid. Med. Cell. Longev. 17, 8421394 (2018)
M. Guo, Z. Liu, J. Willen, C.P. Shaw, D. Richard, E. Jagoda et al. Epigenetic profiling of growth plate chondrocytes sheds insight into regulatory genetic variation influencing height. Elife 6, pii: e29329 (2017)
A. Marchini, T. Marttila, A. Winter, S. Caldeira, I. Malanchi, R.J. Blaschke et al. The short stature homeodomain protein SHOX induces cellular growth arrest and apoptosis and is expressed in human growth plate chondrocytes. J. Biol. Chem. 279, 37103–37114 (2004)
G. Binder, Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm. Res. Paediatr. 75, 81–89 (2011)
A. Marchini, T. Ogata, G.A. Rappold, A track record on SHOX: from basic research to complex models and therapy. Endocr. Rev. 37, 417–448 (2016)
V. Belin, V. Cusin, G. Viot, D. Girlich, A. Toutain, A. Moncla et al. SHOX mutations in dys-chondrosteosis (Leri-Weill syndrome). Nat. Genet. 19, 67–69 (1998)
M.J. Kang, Novel genetic cause of idiopathic short stature. Ann. Pediatr. Endocrinol. Metab. 22, 153–157 (2017)
E. Rao, B. Weiss, M. Fukami, A. Rump, B. Niesler, A. Mertz et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat. Genet. 16, 54–63 (1997)
A.C. Malaquias, R.C. Scalco, E.G. Fontenele, E.F. Costalonga, A.D. Baldin, A.F. Braz et al. The sitting height/height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis. Horm. Res. Paediatr. 80, 449–456 (2013)
G. Binder, G.A. Rappold, in SHOX Deficiency Disorders, ed. by M.P. Adam, H.H. Ardinger, R.A. Pagon, S.E. Wallace, L.J.H. Bean, K. Stephens, A. Amemiya, GeneReviews® [Internet] (University of Washington: Seattle, WA, 1993–2020) 2005 Dec 12 [updated 2018 Jun 28].
J.C. Lui, O. Nilsson, Y. Chan, C.D. Palmer, A.C. Andrade et al. Synthesizing genome-wide association studies and expression microarray reveals novel genes that act in the human growth plate to modulate height. Hum. Mol. Genet. 21, 5193–5201 (2012)
L.R. Potter, S. Abbey-Hosch, D.M. Dickey, Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr. Rev. 27, 47–72 (2006)
K. Pejchalova, P. Krejci, W.R. Wilcox, C-natriuretic peptide: an important regulator of cartilage. Mol. Genet. Metab. 92, 210–215 (2007)
A. Ozasa, Y. Komatsu, A. Yasoda, M. Miura, Y. Sakuma, Y. Nakatsuru et al. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. Bone 36, 1056–1064 (2005)
P. Krejci, B. Masri, V. Fontaine, P.B. Mekikian, M. Weis, H. Prats et al. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J. Cell Sci. 118(Pt 21), 5089–50100 (2005)
C.F. Bartels, H. Bukulmez, P. Padayatti, D.K. Rhee, C. van Ravenswaaij-Arts, R.M. Pauli et al. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am. J. Hum. Genet. 75, 27–34 (2004)
R.C. Olney, H. Bukulmez, C.F. Bartels, T.C. Prickett, E.A. Espiner, L.R. Potter et al. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. J. Clin. Endocrinol. Metab. 91, 1229–1232 (2006)
G.A. Vasques, N. Amano, A.J. Docko, M.F. Funari, E.P. Quedas, M.Y. Nishi et al. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature. J. Clin. Endocrinol. Metab. 98, E1636–E1644 (2013)
S.R. Wang, C.M. Jacobsen, H. Carmichael, A.B. Edmund, J.W. Robinson, R.C. Olney et al. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature. Hum. Mutat. 36, 474–481 (2015)
A. Hisado-Oliva, A. Ruzafa-Martin, L. Sentchordi, M.F.A. Funari, C. Bezanilla-Lopez, M. Alonso-Bernaldez et al. Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature. Genet. Med. 20, 91–97 (2018)
Z. Liu, K.J. Lavine, I.H. Hung, D.M. Ornitz, FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev. Biol. 302, 80–91 (2007)
I.H. Hung, K. Yu, K.J. Lavine, D.M. Ornitz, FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod. Dev. Biol. 307, 300–313 (2007)
D.M. Ornitz, P.J. Marie, Fibroblast growth factors in skeletal development. Curr. Top. Dev. Biol. 133, 195–234 (2019)
A. Yasoda, Y. Komatsu, H. Chusho, T. Miyazawa, A. Ozasa, M. Miura et al. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat. Med. 10, 80–86 (2004)
S.G. Kant, I. Cervenkova, L. Balek, L. Trantirek, G.W. Santen, M.C. de Vries et al. A novel variant of FGFR3 causes proportionate short stature. Eur. J. Endocrinol. 172, 763–770 (2015)
L. Plachy, V. Strakova, L. Elblova, B. Obermannova, S. Kolouskova, M. Snajderova, High prevalence of growth plate gene variants in children with familial short stature treated with GH. J. Clin. Endocrinol. Metab. 104, 4273–4281 (2019)
B. Lanske, A.C. Karaplis, K. Lee, A. Luz, A. Vortkamp, A. Pirro et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273, 663–666 (1996)
A. Vortkamp, K. Lee, B. Lanske, G.V. Segre, H.M. Kronenberg, C.J. Tabin, Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273, 613–622 (1996)
J.M. Kindblom, O. Nilsson, T. Hurme, C. Ohlsson, L. Savendahl, Expression and localization of Indian hedgehog (Ihh) and parathyroid hormone related protein (PTHrP) in the human growth plate during pubertal development. J. Endocrinol. 174, R1–R6 (2002)
A.J. Will, G. Cova, M. Osterwalder, W.L. Chan, L. Wittler, N. Brieske et al. Composition and dosage of a multipartite enhancer cluster control developmental expression of Ihh (Indian hedgehog). Nat. Genet. 49, 1539–1545 (2017)
G.A. Vasques, M.F.A. Funari, F.M. Ferreira, M. Aza-Carmona, L. Sentchordi-Montané, J. Barraza-García et al. IHH gene mutations causing short stature with nonspecific skeletal abnormalities and response to growth hormone therapy. J. Clin. Endocrinol. Metab. 103, 604–614 (2018)
K.L. Lauing, M. Cortes, M.S. Domowicz, J.G. Henry, A.T. Baria, N.B. Schwartz, Aggrecan is required for growth plate cytoarchitecture and differentiation. Dev. Biol. 396, 224–236 (2014)
M. Cortes, A.T. Baria, N.B. Schwartz, Sulfation of chondroitin sulfate proteoglycans is necessary for proper indian hedgehog signaling in the developing growth plate. Development 136, 1697–1706 (2009)
N.B. Schwartz, M. Domowicz, Chondrodysplasias due to proteoglycan defects. Glycobiology 12, 57R–68R (2002)
L. Gleghorn, R. Ramesar, P. Beighton, G. Wallis, A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis. Am. J. Hum. Genet. 77, 484–490 (2005)
O. Nilsson, M.H. Guo, N. Dunbar, J. Popovic, D. Flynn, C. Jacobsen et al. Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations. J. Clin. Endocrinol. Metab. 99, E1510–E1518 (2014)
M. Aza-Carmona, V. Barca-Tierno, A. Hisado-Oliva, A. Belinchón, D. Gorbenko-del Blanco, J.I. Rodriguez et al. NPPB and ACAN, two novel SHOX2 transcription targets implicated in skeletal development. PLoS One 8(9), e83104 (2014)
J.B. Quintos, M.H. Guo, A. Dauber, Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene. J. Pediatr. Endocrinol. Metab. 28, 927–932 (2015)
A. Gkourogianni, M. Andrew, L. Tyzinski, M. Crocker, J. Douglas, N. Dunbar et al. Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations. J. Clin. Endocrinol. Metab. 102, 460–469 (2017)
S. Dateki, A. Nakatomi, S. Watanabe, H. Shimizu, Y. Inoue, H. Baba et al. Identification of a novel heterozygous mutation of the Aggrecan gene in a family with idiopathic short stature and multiple intervertebral disc herniation. J. Hum. Genet. 62, 717–721 (2017)
N.N. Hauer, H. Sticht, S. Boppudi, C. Büttner, C. Kraus, U. Trautmann et al. Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature. Sci. Rep. 7, 12225 (2017)
M. van der Steen, R. Pfundt, S.J.W.H. Maas, W.M. Bakker-van Waarde, R.J. Odink, A.C.S. Hokken-Koelega, ACAN gene mutations in short children born SGA and response to growth hormone treatment. J. Clin. Endocrinol. Metab. 5, 1458–1467 (2017)
C. Tatsi, A. Gkourogianni, K. Mohnike, D. DeArment, S. Witchel, A.C. Andrade et al. Aggrecan mutations in nonfamilial short stature and short stature without accelerated skeletal maturation. J. Endocr. Soc. 1, 1006–1011 (2017)
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Faienza, M.F., Chiarito, M., Brunetti, G. et al. Growth plate gene involment and isolated short stature. Endocrine 71, 28–34 (2021). https://doi.org/10.1007/s12020-020-02362-w
- Growth plate
- Isolated short stature